NEU 1.33% $20.73 neuren pharmaceuticals limited

Investee, I understand your thoughtful comments re NEU. The last...

  1. 185 Posts.
    lightbulb Created with Sketch. 65
    Investee, I understand your thoughtful comments re NEU. The last para is perhaps the most important. I think the key benefit for NEU in raising more capital is increased 'Optionality'. The comparison charts of NEU (blue) with XAO (orange) speak for themselves. The capital raising should give NEU management & board additional power to execute plans that will enable long-standing SHs to exit with a fair ROI. I'd be wary if there are increases in Director's fees & Management remuneration

    Not professional advice : please do your own DD

    https://hotcopper.com.au/data/attachments/3577/3577652-2ff202c95fd49cece550170d07aa0d18.jpg

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.73
Change
-0.280(1.33%)
Mkt cap ! $2.647B
Open High Low Value Volume
$20.87 $21.19 $20.70 $6.213M 297.7K

Buyers (Bids)

No. Vol. Price($)
4 5414 $20.72
 

Sellers (Offers)

Price($) Vol. No.
$20.79 335 1
View Market Depth
Last trade - 16.10pm 21/05/2024 (20 minute delay) ?
Last
$20.73
  Change
-0.280 ( 1.22 %)
Open High Low Volume
$20.99 $21.19 $20.69 94423
Last updated 15.59pm 21/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.